Literature DB >> 15036435

Severe congenital factor X deficiency with intracranial bleeding in two siblings.

Bahri Ermis1, Rahmi Ors, Ayhan Tastekin, Fatih Orhan.   

Abstract

Congenital factor X deficiency is a rare autosomal recessive disorder that usually presents with variable bleeding tendency, prolonged prothrombin time and partial thromboplastin time. Therefore, it may be misdiagnosed as hemorrhagic disease of the newborn. Factor X level should be investigated for the definite diagnosis. We first report a new family whose two infants presented with severe intracranial bleeding at different times and were found to have congenital factor X deficiency. Plasma replacement therapy was not found to be efficacious in these infants. In conclusion, a possible factor X deficiency should be considered when a newborn presents with intracranial bleeding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036435     DOI: 10.1016/S0387-7604(03)00119-0

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Intracranial hemorrhage in children with congenital factor deficiencies.

Authors:  Turkan Patiroglu; Mehmet Akif Ozdemir; Ekrem Unal; Yasemin Altuner Torun; Abdulhakim Coskun; Ahmet Menku; Fatma Turkan Mutlu; Musa Karakukcu
Journal:  Childs Nerv Syst       Date:  2011-07-12       Impact factor: 1.475

Review 2.  Management of coagulopathy in the setting of acute neurosurgical disease and injury.

Authors:  Marlon Mathews; Richard Newman; E Thomas Chappell
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  An analysis of 8 cases of factor X deficiency.

Authors:  Nilam M Shah; Ashwin P Patel
Journal:  Indian J Hematol Blood Transfus       Date:  2008-05-01       Impact factor: 0.900

4.  Traumatic shaking: The role of the triad in medical investigations of suspected traumatic shaking.

Authors:  Göran Elinder; Anders Eriksson; Boubou Hallberg; Niels Lynøe; Pia Maly Sundgren; Måns Rosén; Ingemar Engström; Björn-Erik Erlandsson
Journal:  Acta Paediatr       Date:  2018-09       Impact factor: 2.299

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.